archTIS extends A$4M CBA facility to April 2027
archTIS (ASX:AR9, OTCQB:ARHLF) has agreed an extension of the maturity date of its A$4M Commonwealth Bank of Australia (CBA) facility, from 30 October 2026 to 30 April 2027. The extension provides continued access to non-dilutive funding.
The A$4M facility is part of the Company’s total A$8M in CBA facilities, as disclosed in the ASX Announcement dated 15 July 2026. The extension is intended to support ongoing contract execution as archTIS continues to meet growing demand for its data-centric security products.
No new equity is being issued and existing shareholders are not diluted. For investors, the near-term maturity has been pushed out by six months without costing shareholders any equity.
When big ASX news breaks, our subscribers know first
Updated CBA facility structure
Following the extension, the Company’s CBA financing facilities comprise three tranches. Only the A$4M facility has changed.
| Facility | Amount | Maturity date | Status | Change |
|---|---|---|---|---|
| CBA facility 1 | A$2M | 29 January 2027 | Unchanged | n/a |
| CBA facility 2 | A$2M | 31 January 2027 | Unchanged | n/a |
| CBA facility 3 | A$4M | 30 April 2027 | Extended | Previously 30 October 2026 |
Terms attached to the extension are limited:
- A one-off establishment fee of A$2,000 applies to the variation and the extension of the maturity date for the A$4M facility.
- Otherwise, the key terms of the facilities remain unchanged from what was previously disclosed to the market.
The low one-off cost and unchanged key terms point to a low-friction renewal.
The earlier CBA extension to 30 October 2026 followed the same pattern, with key terms preserved and only a A$2,000 establishment fee added.
Why non-dilutive funding matters for investors
Non-dilutive funding is money raised without issuing new shares, such as a bank facility. Raising equity, by contrast, creates additional shares and reduces each existing shareholder’s percentage ownership.
Working capital funding covers the gap between delivering work on contracts and receiving payment for it. archTIS states that maintaining bank debt on competitive terms supports its capital-efficient funding of working capital requirements, without issuing new equity or diluting existing shareholders.
Contract timing is the live issue for working capital, with a second U.S. DoD contract worth A$315,000 to be recognised in FY27 and an enterprise license valued at A$7.5M-A$15M annually expected in Q2 FY27.
Management says CBA extension reflects confidence
Managing Director and CEO Daniel Lai commented on the extension and its role in the Company’s approach to capital management.
Daniel Lai, Managing Director and CEO
“We are pleased to have extended our financing arrangements with CBA and appreciate their continued support. The facility extension reflects CBA’s confidence in the Company and our ability to continue executing our strategy. Access to flexible, non-dilutive bank funding remains an important part of our disciplined approach to capital management, allowing us to support growth while preserving value for shareholders.”
The takeaway for investors is that disciplined capital management allows growth to be supported while preserving value for shareholders.
Key dates ahead for the CBA facilities
The maturity dates for the Company’s CBA facilities following the extension are:
- A$2M CBA facility matures on 29 January 2027.
- A$2M CBA facility matures on 31 January 2027.
- A$4M CBA facility (extended) matures on 30 April 2027.
Don’t Miss the Next Tech Winner on the ASX
Join 20,000+ investors getting FREE breaking ASX tech news in their inbox within minutes of release, complete with in-depth analysis. Click the “Free Alerts” button at Big News Blast to receive real-time alerts the moment market-moving announcements land, and stay ahead of the market.